Acadian Asset Management
DTIL icon

Acadian Asset Management’s Precision BioSciences DTIL Stock Holding History

Acadian Asset Management’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.4M Buy
305,759
+260,991
+583% +$1.84M ﹤0.01% 1033
2026
Q1 		$244K Sell
44,768
-11,547
-21% -$53.3K ﹤0.01% 1533
2025
Q4 		$233K Sell
56,315
-63,044
-53% -$358K ﹤0.01% 1488
2025
Q3 		$658K Sell
119,359
-106,578
-47% -$510K ﹤0.01% 1151
2025
Q2 		$948K Sell
225,937
-22,683
-9% -$112K ﹤0.01% 992
2025
Q1 		$1.18M Hold
248,620
– – ﹤0.01% 888
2024
Q4 		$946K Buy
248,620
+98,440
+66% +$719K ﹤0.01% 938
2024
Q3 		$1.34M Buy
150,180
+39,407
+36% +$379K ﹤0.01% 858
2024
Q2 		$1.08M Sell
110,773
-3,499
-3% -$41.2K ﹤0.01% 969
2024
Q1 		$1.55M Buy
114,272
+2,808
+3% +$34.4K 0.01% 725
2023
Q4 		$1.22M Buy
111,464
+6,523
+6% +$70.3K ﹤0.01% 804
2023
Q3 		$1.07M Buy
104,941
+8,080
+8% +$124K ﹤0.01% 840
2023
Q2 		$1.53M Hold
96,861
– – 0.01% 771
2023
Q1 		$2.19M Buy
96,861
+7,278
+8% +$240K 0.01% 681
2022
Q4 		$3.2M Buy
89,583
+13,167
+17% +$520K 0.02% 558
2022
Q3 		$2.98M Buy
76,416
+1,641
+2% +$78K 0.02% 528
2022
Q2 		$3.59M Buy
74,775
+41,210
+123% +$2.42M 0.02% 490
2022
Q1 		$3.1M Buy
33,565
+20,647
+160% +$2.81M 0.01% 565
2021
Q4 		$2.87M Buy
12,918
+8,134
+170% +$2.27M 0.01% 574
2021
Q3 		$1.66M Buy
4,784
+3,405
+247% +$1.15M 0.01% 727
2021
Q2 		$517K Buy
+1,379
New +$414K ﹤0.01% 1141
2020
Q2 		– Sell
-774
Closed -$140K – 2249
2020
Q1 		$140K Buy
+774
New +$203K ﹤0.01% 1278

Other funds holding DTIL

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Acadian Asset Management's DTIL Position: Q2 2026 in Review

Acadian Asset Management increased its Precision BioSciences (DTIL) stake by 583% in Q2 2026, buying an estimated $1.84M and bringing the position to 305,759 shares worth $2.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1033.

Acadian Asset Management first reported a position in DTIL in Q1 2020 and has held it in 22 quarters since. The position peaked at $3.59M in Q2 2022. 95 funds tracked by Wall St. Rank hold DTIL as of Q2 2026.

  • Acadian Asset Management held 305,759 shares of Precision BioSciences worth $2.4M as of Q2 2026.
  • Acadian Asset Management bought 260,991 Precision BioSciences shares in Q2 2026, an estimated $1.84M.
  • Precision BioSciences made up ﹤0.01% of Acadian Asset Management's portfolio in Q2 2026, its #1033 holding.
  • Acadian Asset Management first reported a position in Precision BioSciences in Q1 2020 and has held it in 22 quarters since.
  • Acadian Asset Management's Precision BioSciences position peaked at $3.59M in Q2 2022.
  • 95 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.